Join an Insightful Webinar on Digital Cognitive Assessments for Early Alzheimer's Clinical Trials
As the urgency to conduct early clinical trials for Alzheimer's disease (AD) intensifies, innovative methods for identifying suitable participants are more important than ever. A valuable opportunity to learn about these approaches is available through an upcoming free webinar hosted by Xtalks, scheduled for December 8, 2026.
In this engaging session, attendees will discover how digital cognitive assessments can effectively assist in participant identification and pre-screening for clinical trials focused on early stages of Alzheimer's disease. The featured speaker, Karra Harrington, PhD, a Principal Scientist and Digital Endpoint Specialist at Cogstate, will cover essential case-finding strategies. These strategies not only aim to identify individuals with cognitive impairment but also enrich the participant pool, ultimately improving recruitment efficiency for clinical studies.
One of the key advantages of digital cognitive assessments lies in their ability to support large-scale recruitment. With the growing need to conduct trials earlier in the AD continuum, these assessments offer a flexible and scalable solution suitable for both site-based and remote recruitment settings. Utilizing real-time scoring and centralized decision-making capabilities, researchers can integrate cognitive data into their screening workflows, making it easier to identify eligible individuals who display signs of cognitive decline or possess biomarkers associated with AD pathology.
However, accessing the full potential of digital cognitive assessments requires well-defined operational criteria and clear decision-making guidelines. This webinar will delve into the critical aspects necessary for developing effective cognitive pre-screening strategies, including insights from clinical trials and observational research.
Participants will learn about various characteristics that make cognitive measures suitable for case-finding applications and the conditions necessary for optimal decision-making. Dr. Harrington will share evidence supporting the use of these digital tools for participant enrichment and identification strategies. By attending, participants pave the way to enhancing the efficiency of trial recruitment processes.
The horizon of Alzheimer's disease research is advancing with digital solutions that promise to streamline the participant screening process significantly. This upcoming webinar is an excellent occasion for healthcare professionals, researchers, and anyone interested in Alzheimer's research to expand their knowledge and stay updated on the latest advancements in clinical trial methodologies.
To participate in the live webinar and gain invaluable insights into the efficacy of digital cognitive assessments in clinical trials, register today. Join us at 11 AM EST (5 PM CET) on December 8, 2026, and be part of an enlightening discussion that could influence future Alzheimer’s research methodologies. Xtalks continues its commitment to empowering the life sciences community by sharing reliable knowledge and collaborative insights essential for making informed decisions in a rapidly evolving field.
For additional information about this free event or to secure your slot, visit the Xtalks website. Don't miss the chance to enhance your expertise in the recruitment strategies for early Alzheimer's clinical trials with cutting-edge digital solutions.